Macular edema managed by cancer treatmentThe use of bevacizumab, popularly known as Avastin, for providing benefit to diabetic patients with macular edema as well as people who develop cystoid macular edema after cataract surgery has been reported by the journal Ophthalmology.

Bevacizumab is presently used to treat some forms of cancer.

It is important to note here that diffuse DME (DDME) is often resistant to laser and other standard treatments and treating DDME with bevacizumab is an amicable treatment options with no serious adverse effects.